Effects of Acupuncture at ST36 and PC6 on Blood Pressure and Endothelial Dysfunction in Hypertensive Patients

Overview

This is randomised, controlled study about effects of acupuncture on blood pressure and endothelial dysfunction in stage I hypertension patient without medication. Subject will receive 8 weeks of either acupuncture or sham acupuncture, measuring FMD and blood test before and after treatment.

Full Title of Study: “Effects of Acupuncture at ST36 and PC6 on Blood Pressure and Endothelial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Participant)
  • Study Primary Completion Date: June 2010

Interventions

  • Procedure: acupuncture
    • acupuncture group : subject will undergo 20minute sessions twice a week for 8weeks. Disposable acupuncture needle(4cm sterilized stainless steel) will be inserted up to 1 cm depth sham acupuncture group : subject will undergo 20 minute. Disposable acupuncture needle(4cm sterilized stainless steel) will be inserted under 1 cm slightly.

Arms, Groups and Cohorts

  • Experimental: traditional acupuncture
    • Procedure : ST 36 and PC 6 are selected, subject will undergo 20minute sessions twice a week for 8weeks. Disposable acupuncture needle(4cm sterilized stainless steel) will be inserted up to 1 cm depth
  • Sham Comparator: sham acupuncture
    • Procedure : Beside 1cm of ST 36 and PC 6 are selected( not meridian point), subject will undergo 20 minute. Disposable acupuncture needle(4cm sterilized stainless steel) will be inserted under 1 cm slightly.

Clinical Trial Outcome Measures

Primary Measures

  • To assess effects of acupuncture on endothelial function with FMD variation after 8 weeks treatments.
    • Time Frame: 8 weeks

Secondary Measures

  • To examine the effects of acupuncture on blood pressure, lipid , hsCRP level variation with ABPM after 8 weeks treatments.
    • Time Frame: 8 weeks

Participating in This Clinical Trial

Inclusion Criteria

  • Patients age 18-70 diagnosed stage I hypertension ( JNC-7) without taking hypertensive medication

Exclusion Criteria

  • Secondary hypertension
  • DM
  • History of cardiovascular disease
  • Taking hypertensive medication
  • Taking hyperlipidemic medication
  • Smoking
  • Pregnancy or feeding woman
  • Cannot follow indication or there is no agreement of patient and conservator
  • Investigator decide Inappropriate to trial

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 70 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Kyunghee University Medical Center
  • Provider of Information About this Clinical Study
    • Oriental Medicine of Stroke & Neurological Disorders Center, Oriental Medicine of Stroke & Neurological Disorders Center
  • Overall Official(s)
    • SeongUk Park, OMD, Principal Investigator, Oriental medicine center of Stroke and Neurology
  • Overall Contact(s)
    • Hyemi Kim, OMD, +82/2/440/8558, muskan0907@gmail.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.